Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Nexalin Technology (NXL) Research & Development (2024 - 2025)

Nexalin Technology (NXL) has 2 years of Research & Development data on record, last reported at $226520.0 in Q3 2025.

  • For Q3 2025, Research & Development rose 26.86% year-over-year to $226520.0; the TTM value through Sep 2025 reached $1.6 million, changed N/A, while the annual FY2024 figure was $1.2 million, 38.03% down from the prior year.
  • Research & Development reached $226520.0 in Q3 2025 per NXL's latest filing, roughly flat from $225774.0 in the prior quarter.
  • Across five years, Research & Development topped out at $737242.0 in Q4 2024 and bottomed at $105668.0 in Q1 2024.